Literature DB >> 31414150

[Computed tomography and/or magnetic resonance imaging of the liver : How, why, what for?]

G H Pöhler1, K I Ringe2.   

Abstract

CLINICAL PROBLEM: Colorectal metastases are the most common malignant liver lesions. Imaging of the liver in patients with colorectal carcinoma is performed for early detection of liver metastases (CRLM) at the time of initial tumor diagnosis, for monitoring and follow-up in order to exclude or diagnose metachronous metastases. STANDARD RADIOLOGICAL
METHODS: Radiological imaging includes primarily multislice computed tomography (CT) and magnetic resonance imaging (MRI), which play an important role regarding therapeutic management and assessment of prognosis. PERFORMANCE, ACHIEVEMENTS: Contrast-enhanced CT is broadly available and allows for rapid image acquisition including the possibility for complete tumor staging. MRI, on the other hand, is characterized by very good soft tissue contrast and has-especially with the use of diffusion-weighted imaging and administration of liver-specific contrast agents-the highest sensitivity for detection of metastases smaller than 1 cm. PRACTICAL RECOMMENDATIONS: The choice of imaging in daily routine is often dependent on availability and clinical question. Frequently, e.g. for assessment of resectability (extent of metastases, anatomic relation of lesions to critical structures), both modalities may be implemented in combination.

Entities:  

Keywords:  Colorectal cancer; Imaging; Liver metastases; Staging; Tumor diagnostics

Mesh:

Year:  2019        PMID: 31414150     DOI: 10.1007/s00117-019-00583-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 2.  CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab.

Authors:  Piyaporn Boonsirikamchai; Mohamed Aly Asran; Dipen M Maru; Jean-Nicolas Vauthey; Harmeet Kaur; Scott Kopetz; Evelyne M Loyer
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

Review 3.  Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis.

Authors:  Irene Floriani; Valter Torri; Eliana Rulli; Daniela Garavaglia; Anna Compagnoni; Luca Salvolini; Andrea Giovagnoni
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

Review 4.  Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

Authors:  Kristina I Ringe; Daniela B Husarik; Claude B Sirlin; Elmar M Merkle
Journal:  AJR Am J Roentgenol       Date:  2010-07       Impact factor: 3.959

5.  Cystic liver metastases from colorectal cancer.

Authors:  Y Sugawara; J Yamamoto; S Yamasaki; K Shimada; T Kosuge; M Sakamoto
Journal:  J Surg Oncol       Date:  2000-06       Impact factor: 3.454

Review 6.  Imaging liver metastases: review and update.

Authors:  Masayuki Kanematsu; Hiroshi Kondo; Satoshi Goshima; Hiroki Kato; Usuke Tsuge; Yoshinobu Hirose; Myeong-Jin Kim; Noriyuki Moriyama
Journal:  Eur J Radiol       Date:  2006-01-10       Impact factor: 3.528

7.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.

Authors:  Maarten Christian Niekel; Shandra Bipat; Jaap Stoker
Journal:  Radiology       Date:  2010-09-09       Impact factor: 11.105

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings.

Authors:  Philippe Soyer; Marc Poccard; Mourad Boudiaf; Martine Abitbol; Lounis Hamzi; Yves Panis; Patrice Valleur; Rolland Rymer
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

Review 10.  Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.

Authors:  Charlotte S van Kessel; Constantinus F M Buckens; Maurice A A J van den Bosch; Maarten S van Leeuwen; Richard van Hillegersberg; Helena M Verkooijen
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.